What Is Cannabidivarin (CBDV)?

Cannabidivarin, commonly abbreviated CBDV, is a naturally occurring minor cannabinoid related structurally to cannabidiol (CBD). It is found in some Cannabis varieties and is studied as a distinct cannabinoid rather than simply a weaker form of CBD. This page provides a neutral overview for readers evaluating cannabinoid identity, research, testing and formulation documentation.

CBDV and CBD: related but different

CBDV and CBD belong to the same broad cannabinoid family, but they have different molecular side-chain structures. That distinction matters for analytical identification, specification writing, research interpretation and product development. A CBDV material should therefore be tested and documented as CBDV, not described only as CBD.

Where CBDV is found

CBDV occurs naturally in certain cannabis chemotypes, usually at varying concentrations. Botanical source, extraction method and purification process influence the final profile. Commercial buyers should request a batch-specific certificate of analysis confirming CBDV identity, potency and the presence or absence of other cannabinoids.

What CBDV research can tell us

Research has examined CBDV in laboratory, preclinical and early human contexts, including pharmacology and neurobiological mechanisms. These findings are scientifically relevant but do not automatically establish a health benefit for a finished product. Evidence quality, dose, route of administration and formulation can differ substantially between studies.

Quality and formulation documentation

• Verified CBDV identity and cannabinoid profile
• Potency results with clear units and analytical method
• Contaminant testing appropriate to the material and intended use
• Specification sheet, SDS and batch traceability
• Storage and stability recommendations

Regulatory and claims caution

The legal status of CBDV materials and finished products varies by jurisdiction and product category. Before commercialisation, businesses should obtain market-specific regulatory advice and ensure that labels, advertising and technical files do not overstate the available evidence.

CBDV for professional evaluation

For formulators and procurement teams, the key questions are identity, purity, consistency, intended application, testing scope and legal acceptability in the destination market. A transparent technical file is more useful than broad claims about effects.

See our CBDV collection, read the cannabinoid science hub, or contact us via the request-for-quote page.